Remicade eases treatment-resistant kids’ arthritis

	Tweet

Children with arthritis—a condition known as juvenile idiopathic arthritis (JIA)—who aren’t helped by conventional treatments may benefit from one of the newer anti-arthritis drugs, Remicade.

Repeated infusions of Remicade, known generically as infliximab, along with methotrexate led to “clinically impressive” results, according to Italian researchers.

In the medical journal Arthritis and Rheumatism, Dr. Valeria Gerloni and colleagues from Istituto G. Pini, Milan, report on a trial of Remicade in 24 young people with JIA. They were given a starting dose of the drug, two more after two and six weeks, and then a dose every 8 weeks thereafter.

All patients were also given weekly injections of methotrexate.

Following the first infusion of infliximab, most of the patients were in “better general condition,” the authors observe. They reported significantly less pain and morning stiffness and had more energy.

However, 12 patients had one or more adverse events, which occurred mainly during infusions and were “usually not serious,” according to the team

The number of joints with active disease fell significantly from an average of 6 at baseline, to 2 at two weeks. By six months and one year, the figure had dropped to zero.

“Despite the fact that this was a very severely affected group of patients,” the team points out that one third “did not have joints with active disease at the last visit.”

The researchers call for further studies, but conclude that Remicade treatment “showed high effectiveness and safety in short and medium-term treatment.”

SOURCE: Arthritis and Rheumatism, February 2005.

----------------------
Related Articles:

Juvenile Rheumatoid Arthritis (JRA)

RELATED STORIES:
Work environment tied to arthritis disability risk   Rheumatoid arthritis raises heart death risk   Glucosamine and chondroitin provide pain relief from arthritis   Childhood Arthritis: Common but Preventable Consequence of Lyme Disease   Alcohol may prevent rheumatoid arthritis   Exercise therapy may aid hip arthritis   Arthritis symptoms worse in African Americans   New Pathway Involved in Rheumatoid Arthritis Identified   Leflunomide useful for drug-resistant juvenile arthritis   Smoking and quitting problematic with arthritis   Elite athletes at greater risk for arthritis   Got Pain?

Comments

[ + Post Your Own ]

Now you're in the public comment zone. What follows is not Armenian Medical Network's stuff; it comes from other people and we don't vouch for it. A reminder: By using this Web site you agree to accept our Terms of Service. Click here to read the Rules of Engagement.

There are no comments for this entry yet. [ + Comment here + ]